子宫切除术与盆底障碍的关联:系统综述与荟萃分析
该系统综述与荟萃分析纳入60项研究共3,567,848名参与者,评估子宫切除术与盆底障碍的关联。结果显示术后10年内尿失禁所有类型风险升高,10年后盆腔器官脱垂和压力性尿失禁风险升高。作者认为咨询子宫切除术时应讨论这些风险,并考虑可接受的药物或非子宫切除术治疗方案。
要点
- 子宫切除术后10年内,非特异性尿失禁、压力性尿失禁、膀胱过度活动症和混合性尿失禁风险均升高。
- 子宫切除术后10年以上,盆腔器官脱垂和压力性尿失禁风险升高。
- 作者建议子宫切除术前咨询应讨论上述风险,并考虑药物或非子宫切除术治疗方案。
核心结论
- 子宫切除术与术后10年内所有类型尿失禁风险升高以及10年后盆腔器官脱垂和压力性尿失禁风险升高存在统计学显著关联。
- 作者认为在子宫切除术咨询时讨论这些风险很重要,并应考虑临床上可接受的药物或非子宫切除术治疗方案。
研究设计与样本
- 系统综述与荟萃分析,检索Medline和Embase自建库至2024年10月11日,无语言限制,注册号CRD42023443210。
- 纳入随机对照研究和报告校正分析的非随机比较研究,对象为因良性指征经任何途径行子宫切除术的成年女性(≥18岁),要求术后随访至少1年。
- 排除因盆底障碍行同期手术者;共纳入60项研究(8项随机对照试验、20项队列研究、32项病例对照研究),参与者3,567,848例。
主要发现
- 术后10年内,子宫切除术与非特异性尿失禁风险升高相关(效应量1.29,95%CI 1.11-1.47;25项研究)。
- 术后10年内,子宫切除术与压力性尿失禁(效应量1.31,95%CI 1.06-1.56;14项研究)、膀胱过度活动症(效应量1.41,95%CI 1.25-1.58;16项研究)和混合性尿失禁(效应量1.62,95%CI 1.40-1.85;3项研究)风险升高相关。
- 术后10年以上,子宫切除术与盆腔器官脱垂(效应量1.56,95%CI 1.35-1.78;6项研究)和压力性尿失禁(效应量2.40,95%CI 2.17-2.63;5项研究)风险升高相关。
关键数值与推荐
- 术后10年内非特异性尿失禁效应量1.29(95%CI 1.11-1.47;25项研究)。
- 术后10年内压力性尿失禁效应量1.31(95%CI 1.06-1.56;14项研究)、膀胱过度活动症效应量1.41(95%CI 1.25-1.58;16项研究)、混合性尿失禁效应量1.62(95%CI 1.40-1.85;3项研究)。
- 术后10年以上盆腔器官脱垂效应量1.56(95%CI 1.35-1.78;6项研究)、压力性尿失禁效应量2.40(95%CI 2.17-2.63;5项研究)。
临床怎么用
- 作者认为子宫切除术咨询时应讨论术后尿失禁、盆腔器官脱垂和压力性尿失禁的风险。
- 作者建议在临床上可接受时考虑药物或非子宫切除术治疗方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hysterectomy is the second most common surgery performed among women in the United States. The associations between hysterectomy and the risk of pelvic floor disorders remain unclear. The objective of this study is to systematically review the associations between hysterectomy and the likelihood of pelvic floor disorders. DATA SOURCES: A systematic search of Medline and Embase from inception to October 11, 2024, was performed without language restrictions. The systematic review was registered in The International Prospective Register of Systematic Reviews (CRD42023443210). STUDY ELIGIBILITY CRITERIA: Studies included randomized controlled studies and nonrandomized comparative studies (that reported adjusted analyses) of adult female individuals aged ≥18 years old who underwent a hysterectomy through any route for benign indications. At least 1 year of follow-up after hysterectomy was required. Studies of individuals undergoing concomitant surgery for pelvic floor disorders were excluded. STUDY APPRAISAL AND SYNTHESIS METHODS: Twelve investigators independently screened each abstract and potentially eligible full-text article in duplicate. Data extraction, risk of bias assessment, and strength of evidence grading were conducted using standard instruments. Meta-analyses were performed using random-effects models. Outcomes included pelvic organ prolapse, urinary incontinence (nonspecific, mixed, and stress), overactive bladder, voiding dysfunction, fecal incontinence, and defecatory dysfunction. Results were stratified by time since hysterectomy (≤10 years vs >10 years). RESULTS: We included 60 studies (8 randomized controlled trials, 20 cohort studies, and 32 case-control studies) with 3,567,848 participants. In the first 10 years, hysterectomy was associated with higher likelihood of (nonspecific) urinary incontinence (effect size 1.29, 95% confidence interval 1.11-1.47; 25 studies), stress urinary incontinence (effect size, 1.31; 95% confidence interval, 1.06-1.56; 14 studies), overactive bladder (effect size, 1.41; 95% confidence interval, 1.25-1.58; 16 studies), and mixed urinary incontinence (effect size, 1.62; 95% confidence interval, 1.40-1.85; 3 studies). Beyond 10 years, hysterectomy was associated with higher likelihood of pelvic organ prolapse (effect size, 1.56; 95% confidence interval, 1.35-1.78; 6 studies) and stress urinary incontinence (effect size, 2.40; 95% confidence interval, 2.17-2.63; 5 studies). CONCLUSION: Hysterectomy is associated with a statistically significant higher likelihood of urinary incontinence of all types within 10 years, as well as pelvic organ prolapse and stress urinary incontinence beyond 10 years after hysterectomy. It is important to discuss these risks at the time of counseling for hysterectomy with consideration of medical or nonhysterectomy treatment options if clinically acceptable.
引用
- Chang OH, Saldanha IJ, Encalada-Soto D, et al. Associations between hysterectomy and pelvic floor disorders: a systematic review and meta-analysis. Am J Obstet Gynecol. 2025. PMID: 40120730. doi:10.1016/j.ajog.2025.03.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。